Ibu, Pedea(ibuprofen)
Advil, Caldolor, Combogesic, Combunox, Duexis, Ibuprohm, Midol, Motrin, Pedea, Reprexain, Sine-aid, Vicoprofen (ibuprofen) is a small molecule pharmaceutical. Ibuprofen was first approved as Ibu on 1982-01-01. It is used to treat ankylosing spondylitis, bursitis, dysmenorrhea, fever, and gout amongst others in the USA. It has been approved in Europe to treat patent ductus arteriosus. The pharmaceutical is active against prostaglandin G/H synthase 2 and prostaglandin G/H synthase 1. In addition, it is known to target peroxisome proliferator-activated receptor gamma, acid-sensing ion channel 1, and sodium-coupled monocarboxylate transporter 1.
Download report
Favorite
Searched
Top Prescription Drugs
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
musculoskeletal diseases | D009140 |
urogenital diseases | D000091642 |
cardiovascular diseases | D002318 |
hereditary congenital and neonatal diseases and abnormalities | D009358 |
skin and connective tissue diseases | D017437 |
nutritional and metabolic diseases | D009750 |
immune system diseases | D007154 |
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
Advil, Caldolor, Midol, Motrin (generic drugs available since 1986-07-15, discontinued: Aches-n-pain, Cap-profen, Elixsure, Ibu, Ibu-tab, Ibuprin, Ibuprohm, Medipren, Nuprin, Rufen, Tab-profen)
CombinationsAdvil, Combogesic, Duexis, Ibuprohm, Motrin, Sine-aid (generic drugs available since 1986-07-15, discontinued: Combunox, Reprexain, Vicoprofen)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acetaminophen
+
Ibuprofen
Chlorpheniramine maleate
+
Ibuprofen
+
Phenylephrine hydrochloride
Chlorpheniramine maleate
+
Ibuprofen
+
Pseudoephedrine hydrochloride
Diphenhydramine citrate
+
Ibuprofen
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADVIL PM | GSK | N-021394 OTC | 2005-12-21 | 1 products, RLD, RS |
Diphenhydramine hydrochloride
+
Ibuprofen
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADVIL PM | GSK | N-021393 OTC | 2005-12-21 | 1 products, RLD, RS |
Famotidine
+
Ibuprofen
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUEXIS | Horizon Pharmaceutical | N-022519 RX | 2011-04-23 | 1 products, RLD, RS |
Hydrocodone bitartrate
+
Ibuprofen
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VICOPROFEN | AbbVie | N-020716 DISCN | 1997-09-23 | 1 products, RLD |
Hide discontinued
Ibuprofen
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
MIDOL LIQUID GELS | BionPharma | N-021472 OTC | 2002-10-18 | 1 products, RLD, RS |
CALDOLOR | Cumberland Pharmaceuticals | N-022348 RX | 2009-06-11 | 2 products, RLD, RS |
ADVIL | GSK | N-018989 OTC | 1984-05-18 | 1 products, RLD, RS |
JUNIOR STRENGTH ADVIL | GSK | N-020267 OTC | 1996-12-13 | 1 products |
ADVIL MIGRAINE LIQUI-GELS | GSK | N-020402 OTC | 2000-03-16 | 1 products, RLD, RS |
ADVIL LIQUI-GELS | GSK | N-020402 OTC | 1995-04-20 | 1 products, RLD, RS |
CHILDREN'S ADVIL-FLAVORED | GSK | N-020589 OTC | 1997-11-07 | 1 products |
CHILDREN'S ADVIL | GSK | N-020589 OTC | 1996-06-27 | 1 products |
INFANT'S ADVIL | GSK | N-020812 OTC | 2000-01-12 | 1 products, RLD, RS |
CHILDREN'S ADVIL | GSK | N-020944 OTC | 1998-12-18 | 1 products |
Show 5 marketed
Show 16 discontinued
Ibuprofen
+
Oxycodone hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COMBUNOX | Forest Laboratories | N-021378 DISCN | 2004-11-26 | 1 products, RLD |
Hide discontinued
Ibuprofen
+
Phenylephrine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADVIL CONGESTION RELIEF | GSK | N-022565 OTC | 2010-05-27 | 1 products, RLD, RS |
Ibuprofen
+
Pseudoephedrine hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADVIL COLD AND SINUS | GSK | N-019771 OTC | 1989-09-19 | 1 products, RLD, RS |
CHILDREN'S ADVIL COLD | GSK | N-021373 OTC | 2002-04-18 | 1 products |
ADVIL COLD AND SINUS | GSK | N-021374 OTC | 2002-05-30 | 1 products, RLD, RS |
SINE-AID IB | Johnson & Johnson | N-019899 OTC | 1992-12-31 | 1 products |
CHILDREN'S MOTRIN COLD | Johnson & Johnson | N-021128 OTC | 2000-08-01 | 1 products, RLD, RS |
Ibuprofen sodium
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADVIL | GSK | N-201803 OTC | 2012-06-12 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
advil dual action with acetaminophen | New Drug Application | 2023-04-13 |
caldolor | New Drug Application | 2021-04-30 |
duexis | New Drug Application | 2021-06-08 |
ibuprofen | ANDA | 2023-06-17 |
midol complete | OTC monograph not final | 2023-04-26 |
motrin ib | ANDA | 2023-05-18 |
reprexain | ANDA | 2009-10-27 |
vicoprofen | New Drug Application | 2011-08-12 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
ankylosing spondylitis | EFO_0003898 | D013167 | M45 |
bursitis | EFO_1000941 | D002062 | M71.9 |
dysmenorrhea | HP_0100607 | D004412 | N94.6 |
fever | HP_0001945 | D005334 | R50.9 |
gout | EFO_0004274 | D006073 | M10 |
inflammation | MP_0001845 | D007249 | — |
juvenile arthritis | EFO_0002609 | D001171 | M08 |
menorrhagia | HP_0000132 | D008595 | N92.0 |
osteoarthritis | EFO_0002506 | D010003 | M15-M19 |
postoperative pain | — | D010149 | G89.18 |
Show 2 more
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
ACETAMINOPHEN / IBUPROFEN, COMBOGESIC, AFT PHARMS LTD | |||
2026-03-01 | NP | ||
IBUPROFEN, CALDOLOR, CUMBERLAND PHARMS | |||
2024-11-19 | M-128 | ||
ACETAMINOPHEN / IBUPROFEN, ADVIL DUAL ACTION WITH ACETAMINOPHEN, GLAXOSMITHKLINE | |||
2023-02-28 | NP |
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Acetaminophen / Ibuprofen, Combogesic, Aft Pharms Ltd | |||
11197830 | 2039-02-27 | DP | U-3553 |
11534407 | 2039-02-27 | DP | U-3553 |
10532036 | 2025-09-22 | U-3553 | |
Ibuprofen, Caldolor, Cumberland Pharms | |||
9072661 | 2032-03-16 | U-2264 | |
9072710 | 2032-03-16 | U-2266 | |
9012508 | 2030-09-14 | U-981 | |
8735452 | 2029-09-30 | U-981 | |
8871810 | 2029-09-30 | U-981 | |
9114068 | 2029-09-30 | U-1735 | |
9138404 | 2029-09-30 | U-1756 | |
9295639 | 2029-09-30 | U-1756 | |
9649284 | 2029-09-30 | U-2018 | |
Chlorpheniramine Maleate / Ibuprofen / Pseudoephedrine Hydrochloride, Advil Allergy Sinus, Glaxosmithkline | |||
7863287 | 2027-02-28 | DP | |
Famotidine / Ibuprofen, Duexis, Horizon | |||
8067451 | 2026-07-18 | DP | U-1196 |
8309127 | 2026-07-18 | DP | |
8318202 | 2026-07-18 | DP | |
8449910 | 2026-07-18 | DP | |
8501228 | 2026-07-18 | U-1196 | |
Chlorpheniramine Maleate / Ibuprofen / Pseudoephedrine Hydrochloride, Children'S Advil Allergy Sinus, Glaxosmithkline | |||
10238640 | 2024-05-25 | DP |
ATC Codes
C: Cardiovascular system drugs
— C01: Cardiac therapy drugs
— C01E: Other cardiac preparations in atc
— C01EB: Other plain cardiac preparations in atc
— C01EB16: Ibuprofen
G: Genito urinary system and sex hormones
— G02: Other gynecologicals in atc
— G02C: Other gynecologicals in atc
— G02CC: Antiinflammatory products for vaginal administration
— G02CC01: Ibuprofen
M: Musculo-skeletal system drugs
— M01: Antiinflammatory and antirheumatic products
— M01A: Antiinflammatory and antirheumatic products, non-steroids
— M01AE: Propionic acid derivatives, antiinflammatory and antirheumatic products
— M01AE01: Ibuprofen
— M01AE51: Ibuprofen, combinations
— M02: Topical products for joint and muscular pain
— M02A: Topical products for joint and muscular pain
— M02AA: Antiinflammatory preparations, non-steroids for topical use
— M02AA13: Ibuprofen
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AJ: Opioids in combination with non-opioid analgesics
— N02AJ08: Codeine and ibuprofen
— N02AJ19: Oxycodone and ibuprofen
R: Respiratory system drugs
— R02: Throat preparations
— R02A: Throat preparations
— R02AX: Other throat preparations in atc
— R02AX02: Ibuprofen
HCPCS
Code | Description |
---|---|
J1741 | Injection, ibuprofen, 100 mg |
Clinical
Clinical Trials
666 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | 12 | 12 | 25 | 27 | 13 | 88 |
Postoperative pain | D010149 | G89.18 | 4 | 8 | 13 | 22 | 12 | 58 | |
Healthy volunteers/patients | — | 40 | — | — | 3 | 2 | 45 | ||
Patent ductus arteriosus | D004374 | HP_0001643 | Q25.0 | 2 | 9 | 10 | 9 | 12 | 39 |
Fever | D005334 | HP_0001945 | R50.9 | 2 | — | 5 | 10 | 3 | 20 |
Low back pain | D017116 | HP_0003419 | M54.5 | — | 2 | 4 | 10 | 2 | 17 |
Acute pain | D059787 | R52 | 2 | 2 | 5 | 7 | 1 | 17 | |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 3 | 3 | 6 | 2 | — | 14 |
Analgesia | D000698 | — | 2 | 6 | 6 | — | 13 | ||
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 3 | 2 | — | 3 | 5 | 12 |
Show 86 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | 1 | 1 | — | 4 | 6 |
Hiv | D006678 | O98.7 | 1 | 1 | 1 | — | 4 | 6 | |
Neoplasms | D009369 | C80 | — | 2 | 1 | — | 2 | 5 | |
Local anesthesia | D000772 | — | 2 | 1 | — | 1 | 3 | ||
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | 1 | — | 1 | 3 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | 1 | — | 1 | 3 |
Altitude sickness | D000532 | EFO_1000782 | T70.29 | 1 | — | 1 | — | 1 | 3 |
Impacted tooth | D014095 | HP_0011079 | K01.1 | — | 1 | 2 | — | 1 | 3 |
Sprains and strains | D013180 | — | — | 3 | — | — | 3 | ||
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | 1 | — | — | 2 |
Show 41 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Brain concussion | D001924 | S06.0 | — | 1 | — | — | 2 | 3 | |
Unsafe sex | D047568 | — | 1 | — | — | 2 | 3 | ||
Cognitive dysfunction | D060825 | G31.84 | — | 1 | — | — | 2 | 3 | |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 2 | — | — | — | 2 |
Phimosis | D010688 | EFO_1001104 | N47.1 | 1 | 1 | — | — | — | 2 |
Paraphimosis | D010263 | EFO_1001086 | N47.2 | 1 | 1 | — | — | — | 2 |
Balanitis | D001446 | EFO_1000833 | N48.1 | 1 | 1 | — | — | — | 2 |
Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | — | 1 | — | — | 1 | 2 |
Malaria | D008288 | EFO_0001068 | B54 | 1 | 2 | — | — | — | 2 |
Abdominal hernia | D046449 | K46 | — | 1 | — | — | 1 | 2 |
Show 30 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Therapeutic equivalency | D013810 | 5 | — | — | — | — | 5 | ||
Sexually transmitted diseases | D012749 | A50-A64 | 1 | — | — | — | 3 | 4 | |
Pharmacokinetics | D010599 | 1 | — | — | — | 1 | 2 | ||
Drug interactions | D004347 | 1 | — | — | — | — | 1 | ||
Pure autonomic failure | D054970 | 1 | — | — | — | — | 1 | ||
Orthostatic hypotension | D007024 | I95.1 | 1 | — | — | — | — | 1 | |
Hematologic neoplasms | D019337 | 1 | — | — | — | — | 1 | ||
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 1 | — | — | — | — | 1 | |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 1 | — | — | — | — | 1 | |
Hodgkin disease | D006689 | C81 | 1 | — | — | — | — | 1 |
Show 11 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 5 | 5 |
Motor skills disorders | D019957 | F82 | — | — | — | — | 4 | 4 | |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | — | 3 | 3 |
Orientation | D009949 | — | — | — | — | 2 | 2 | ||
Hiv-2 | D015498 | — | — | — | — | 2 | 2 | ||
Leg ulcer | D007871 | — | — | — | — | 2 | 2 | ||
Colonic neoplasms | D003110 | C18 | — | — | — | — | 1 | 1 | |
Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
Urinary calculi | D014545 | N20.9 | — | — | — | — | 1 | 1 | |
Pediatric obesity | D063766 | — | — | — | — | 1 | 1 |
Show 60 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | IBUPROFEN |
INN | ibuprofen |
Description | Ibuprofen is a monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, an antipyretic, a xenobiotic, an environmental contaminant, a radical scavenger, a drug allergen and a geroprotector. It is functionally related to a propionic acid. It is a conjugate acid of an ibuprofen(1-). |
Classification | Small molecule |
Drug class | anti-inflammatory/analgesic agents (ibuprofen type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)Cc1ccc(C(C)C(=O)O)cc1 |
Identifiers
PDB | — |
CAS-ID | 15687-27-1 |
RxCUI | — |
ChEMBL ID | CHEMBL521 |
ChEBI ID | 5855 |
PubChem CID | 3672 |
DrugBank | DB01050 |
UNII ID | WK2XYI10QM (ChemIDplus, GSRS) |
Target
Agency Approved
PTGS2
PTGS2
PTGS1
PTGS1
Organism
Homo sapiens
Gene name
PTGS2
Gene synonyms
COX2
NCBI Gene ID
Protein name
prostaglandin G/H synthase 2
Protein synonyms
COX-2, cyclooxygenase 2, cyclooxygenase 2b, Cyclooxygenase-2, PGH synthase 2, PGHS-2, PHS II, Prostaglandin H2 synthase 2, Prostaglandin-endoperoxide synthase 2, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
Uniprot ID
Mouse ortholog
Ptgs2 (19225)
prostaglandin G/H synthase 2 (Q543K3)
Alternate
PPARG
PPARG
ASIC1
ASIC1
SLC5A8
SLC5A8
Organism
Homo sapiens
Gene name
PPARG
Gene synonyms
NR1C3
NCBI Gene ID
Protein name
peroxisome proliferator-activated receptor gamma
Protein synonyms
Nuclear receptor subfamily 1 group C member 3, peroxisome proliferator-activated receptor-gamma 5, peroxisome proliferator-activated receptor-gamma splicing, PPAR-gamma
Uniprot ID
Mouse ortholog
Pparg (19016)
peroxisome proliferator-activated receptor gamma (P37238)
Variants
Clinical Variant
No data
Financial
Duexis - Horizon Therapeutics Public
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Caldolor - Cumberland Pharmaceuticals
$
€
£
₣
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 44,802 documents
View more details
Safety
Black-box Warning
Black-box warning for: Caldolor, Duexis
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
104,509 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more